Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation - Wikidata - awgldk - TriplyDB

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

http://www.wikidata.org/entity/Q35021902

about

Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus The role of oxidative stress and inflammation in cardiovascular aging Untangling the Gordian knot of HIV, stress, and cognitive impairment High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.Factors Associated With Plasma IL-6 Levels During HIV Infection.Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort.Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Stu The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial Dysfunction.Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study.Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection.Epidemiology of ischemic heart disease in HIV.HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study.Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.Acute coronary syndromes in patients with HIV.Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012.Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.Subclinical atherosclerosis in low Framingham risk HIV patients.Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV Infection.Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People.Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy.Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection

P2860

Q26774828-87D0AD29-D425-4411-A024-6C4D6E73CA50 Q26851535-5EB43031-EDE6-4775-B9F0-8BDA38A2A9C0 Q26864987-6F73ED64-03F9-4EC9-9DD5-D782C9F83D35 Q28067483-E9A4FAAE-231F-4C2A-A87F-83F36D2C5380 Q33764308-4E3D1C6A-B797-4A64-9B54-17E3A895F787 Q35072020-3159DBBE-82F3-4097-9BB6-7F0DFF543158 Q35124939-D6C7E596-FED7-4DE1-87EF-D99A46813396 Q35142189-FF0100E0-9AAD-4BEC-93E3-AE6E20BEEB36 Q35860942-34C9A18C-7739-43DD-BC82-84A44292C445 Q35965242-9F2EA083-84FA-40FF-A0BF-33E48A4F3205 Q35992200-1368541D-7A2A-4131-82E9-23A51C969C28 Q36015621-C0D90B1E-E01A-4CE1-9962-F9C177AB780D Q36139186-AF089C0E-6168-4494-8812-3611EC98B4CC Q36269639-8474D6DD-4F94-45DD-BE1F-4F3B80C183FF Q36309602-44EF5554-7DA1-49A0-84BD-6213F76C713F Q36341298-65DA30C0-38FC-453C-AADC-51894BF10B8D Q36436780-4EC937CB-C5A9-4ACF-89CF-FE976FECE60E Q36535535-6B807BC3-C709-44C3-9C59-BEEB76FAFA52 Q36645092-6F8F693D-2073-48CF-8F67-DC6BE60A275F Q36673883-7DA4B647-F764-4BFE-8B18-D712AEBFF02A Q36745235-CA99A06D-5F1F-4124-B634-DC0158E31CBE Q37076185-F55E3740-9A67-4AB6-9929-2C2C384882B7 Q37643812-1B572588-2065-4028-BB18-CCA4E6D7E9E0 Q38629009-CDC64345-2A80-45F6-A1F7-BFEA3339E135 Q38659387-B55C0A26-525A-4E93-9AEE-E828801F0553 Q38738163-2BCB3267-A5CD-4A10-8A37-6A0271C155CF Q38749963-E72F4AAD-1E79-4AAF-81BA-19B1A400F75F Q38853532-0E65E166-50AF-4278-8549-27AF0FCF0F8B Q38996141-38A9A771-21C0-4DD3-A343-809F6241B030 Q39009201-15B68366-EE68-4DD8-A0A3-53B0F19F3C2B Q39048479-946AF60D-D8CE-4CA5-A054-F5815CE3711D Q39147832-C7B31C0A-1AA9-4C67-96FD-BE2B580FC596 Q39165028-B140BB10-8D7A-4333-AD2D-27C6FD81CAC4 Q39375444-B3B80825-C486-40F1-94FE-3FA051D037D2 Q40075058-3E7B5C71-A9F0-4E2F-9043-2BCD4D3CECB1 Q40140188-19D194E6-543A-4F09-B4E7-00BBC5B0039F Q40458426-B89EC8FE-AD92-4E0B-A851-61CE0FFC591D Q40636584-545310DD-F056-46DA-AD33-607E9F3411F7 Q40675523-3CEDC5D1-C8E1-4192-9195-C7992216D06E Q40692524-D3E7605E-F28B-4FC0-A380-EE9D82AC5458

P2860

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation

http://www.wikidata.org/entity/Q35021902

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Severity of cardiovascular dis ...... f inflammation and coagulation

@ast

Severity of cardiovascular dis ...... f inflammation and coagulation

@en

type

label

Severity of cardiovascular dis ...... f inflammation and coagulation

@ast

Severity of cardiovascular dis ...... f inflammation and coagulation

@en

prefLabel

Severity of cardiovascular dis ...... f inflammation and coagulation

@ast

Severity of cardiovascular dis ...... f inflammation and coagulation

@en

P1433

Q35021902-8593C958-7C16-4E68-9BD1-1D94821A1254

P1476

Q35021902-B0BAC4D3-620E-43B1-A384-5C0A3218EDD4

P2093

Q35021902-34B9ADCF-CFEC-43E0-8A92-13D4A24A2588

Q35021902-3A242EF3-CE0F-4EBE-8BCF-4AD0D30D6696

Q35021902-52F78BC6-E4A4-4323-B896-EC9B63177218

Q35021902-54DAFD09-C034-4E83-A7FF-3A314D5CF055

Q35021902-9B12E2A4-F97D-45E3-A2BC-4DE3E0AA5B58

Q35021902-BF6C4837-7BF5-4E8D-88D7-6939B6F94EA9

Q35021902-E8913EF3-878B-4C2F-8792-9D9906083272

Q35021902-F878876B-61EE-4307-9360-7DF28286F05F

P2860

Q35021902-0634A193-E3BE-4409-AABB-51A4A1DEDC57

Q35021902-185D7048-084A-4754-98D4-BABFFA3CED50

Q35021902-1BB41E23-6377-47B1-B753-19552E9C9763

Q35021902-1D2062A1-408B-4CA4-9947-7652847B84EA

Q35021902-1DB6FA72-33F0-438E-B9B5-A5F058D6F304

Q35021902-26979572-FDE4-417F-8FC1-0D4649D3A6AF

Q35021902-283F496D-3415-4B66-96F0-7A257EBB4132

Q35021902-42F6493B-2842-4C57-BA8B-00168ECBF7B1

Q35021902-487ED3AF-BB1D-4506-B875-61CD703C9BB4

Q35021902-4E558A9C-9CE6-4D88-BBB8-A123C31F83EA

P304

Q35021902-22B1767B-AB72-41DD-91B2-C4D751403B4E

P31

Q35021902-51624BAD-57E5-46EC-8F80-38DF701AAB94

P356

Q35021902-C7669773-652B-4CCD-A47D-0149C06F6465

P433

Q35021902-175D0B41-E4EE-4BAD-8817-CE9139734DF2

P478

Q35021902-E0306569-8654-41B3-94F4-E58E33BAB80E

P577

Q35021902-E97807D5-C48C-4F8E-8089-42DCD1635DC1

P698

Q35021902-06043232-D4A3-4179-A13D-0B119FAB4C34

P921

Q35021902-6ED2E251-6D68-4EDF-B3C3-7E60DA50E539

P932

Q35021902-E75EAF8D-FF16-45B7-9B99-6762859EA0EF

P356

JAHA.114.000844

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Severity of cardiovascular dis ...... f inflammation and coagulation

@en

P2093

Anna D Nordell

http://www.w3.org/2001/XMLSchema#string

Daniel Duprez

http://www.w3.org/2001/XMLSchema#string

INSIGHT SMART, ESPRIT Study Groups

http://www.w3.org/2001/XMLSchema#string

Jacqueline Neuhaus

http://www.w3.org/2001/XMLSchema#string

James D Neaton

http://www.w3.org/2001/XMLSchema#string

Matthew McKenna

http://www.w3.org/2001/XMLSchema#string

SILCAAT Scientific Committee

http://www.w3.org/2001/XMLSchema#string

Álvaro H Borges

http://www.w3.org/2001/XMLSchema#string

P2860

HIV infection and the risk of acute myocardial infarction.

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

CD4+ count-guided interruption of antiretroviral treatment

Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?

Systemic effects of inflammation on health during chronic HIV infection

Interleukin-2 therapy in patients with HIV infection.

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Cardiovascular management of septic shock.

P304

e000844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.114.000844

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24870935

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4309077

http://www.w3.org/2001/XMLSchema#string